protocols
진행프로토콜
PROTOCOLS / 연구참여방법 / 진행프로토콜
| 시험일련번호 | [종료] [완료] KROG 11 - 08 | ||||||
|---|---|---|---|---|---|---|---|
| 임상실험명 | 진단 시 림프절전이가 있는 자궁암 환자에서 세기조절방사선치료를 이용한 고용량 방사선 치료효과에 관한 제2상 임상시험 | ||||||
| 시험책임자 | 김주영 (국립암센터) | ||||||
| 환자적격성 |
1. Patients (who have been adequately clinically staged) with primary, untreated, histologically confirmed carcinoma of the uterine cervix (including clear cell and small cell carcinoma), with metastatic lymphadenopathies (any of pelvis or para-aortic(PAN) >1.5 cm in short diameter, with/without biopsy proven inguinal[ING]) 2. Patients with ECOG Performance Status of 0, 1, 2 3. Patients with adequate bone marrow function: ANC greater than or equal to 1,500/mcl, platelets greater than or equal to 100,000/mcl at the beginning. 4. Patients with adequate renal function: creatinine equal to or less than 2.0 mg%. 5.Patients who have signed an approved informed consent and authorization. (제외기준) 1. Re-irradiation case 2. Patients who have diagnosis of other malignance tumors other than thyroid cancer. 3. Patients with metastatic lymphadenopathies other than pelvis, PAN and ING (e.g. supraclavicular or mediastinal metastatic lymphadenopathy) 4. Patients with distant organ metastasis (e.g. bone, lung, brain…) |
||||||
| 필요 증례수 | 60명 | ||||||
| 자료 |
| ||||||
| 등재현황 |
|
